Does NITROGLYCERIN Cause Product packaging quantity issue? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product packaging quantity issue have been filed in association with NITROGLYCERIN (Glonoinum). This represents 0.1% of all adverse event reports for NITROGLYCERIN.
6
Reports of Product packaging quantity issue with NITROGLYCERIN
0.1%
of all NITROGLYCERIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From NITROGLYCERIN?
Of the 6 reports, and 1 (16.7%) were considered life-threatening.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NITROGLYCERIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does NITROGLYCERIN Cause?
Drug ineffective (1,269)
Fall (1,183)
Hypotension (1,086)
Pain (952)
Constipation (896)
Headache (890)
Dyspnoea (801)
Malaise (765)
Dizziness (717)
Fatigue (680)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which NITROGLYCERIN Alternatives Have Lower Product packaging quantity issue Risk?
NITROGLYCERIN vs NITROUS
NITROGLYCERIN vs NITROUS\OXYGEN
NITROGLYCERIN vs NIVOLUMAB
NITROGLYCERIN vs NIVOLUMAB\RELATLIMAB-RMBW
NITROGLYCERIN vs NIZATIDINE